Andrew Dickinson

Andrew Dickinson is currently the Chief Financial Officer at Gilead Sciences, leading the finance, corporate development & strategy, operations and information technology organizations. Prior to this, Andrew worked at Lazard as Managing Director, Life Sciences Investment Banking and at Myogen Inc as General Counsel and Vice President Corporate Development. Andrew also co-founded Kendall, Dickinson & Koenig LLC, a law firm specializing in corporate securities, venture capital, and M&A practices. Andrew holds a JD with Honors from Loyola University Chicago and a Bachelor of Arts in Molecular Biology from the University of Colorado Boulder.